Tedeschi, A., Greil, R., Demirkan, F., Robak, T., Moreno, C., Barr, P. M., . . . Gribben, J. G. (2020). A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Haematologica.
Styl ChicagoTedeschi, Alessandra, et al. "A Cross-trial Comparison of Single-agent Ibrutinib Versus Chlorambucil-obinutuzumab in Previously Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma." Haematologica 2020.
Citace podle MLATedeschi, Alessandra, et al. "A Cross-trial Comparison of Single-agent Ibrutinib Versus Chlorambucil-obinutuzumab in Previously Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma." Haematologica 2020.